179 related articles for article (PubMed ID: 20197567)
1. Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries?
Abud-Mendoza C; Martínez-Martínez MU; DE Jesús Macías-Mendoza J; Magaña-Aquino M
J Rheumatol; 2010 Mar; 37(3):672-3; author reply 673. PubMed ID: 20197567
[No Abstract] [Full Text] [Related]
2. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report.
Malaviya AN; Kapoor S; Garg S; Rawat R; Shankar S; Nagpal S; Khanna D; Furst DE
J Rheumatol; 2009 Jul; 36(7):1414-20. PubMed ID: 19487263
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha blocker induced tuberculosis.
Kharbanda P; Dagaonkar R; Balakrishnan C; Udwadia ZF
J Rheumatol; 2010 Jul; 37(7):1542; author reply 1543. PubMed ID: 20595292
[No Abstract] [Full Text] [Related]
4. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
Laffitte E; Janssens JP; Roux-Lombard P; Thielen AM; Barde C; Marazza G; Panizzon RG; Saurat JH
Br J Dermatol; 2009 Oct; 161(4):797-800. PubMed ID: 19659473
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
[No Abstract] [Full Text] [Related]
8. Recommended screening strategy for preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India - followup report.
Malaviya AN; Kapoor S; Garg S; Rawat R
J Rheumatol; 2010 Jan; 37(1):209. PubMed ID: 20040648
[No Abstract] [Full Text] [Related]
9. Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis.
Inanc N; Aydin SZ; Karakurt S; Atagunduz P; Yavuz S; Direskeneli H
J Rheumatol; 2009 Dec; 36(12):2675-81. PubMed ID: 19918035
[TBL] [Abstract][Full Text] [Related]
10. [The relevance of diagnostic criteria for latent tuberculosis before initiation of TNF-alpha inhibitors in psoriasis patients].
Goujon C; Gormand F; Gunera-Saad N; Dahel K; Vial T; Nicolas JF
Ann Dermatol Venereol; 2010; 137(6-7):437-43. PubMed ID: 20620572
[TBL] [Abstract][Full Text] [Related]
11. Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
Keystone EC; Papp KA; Wobeser W
J Rheumatol; 2011 Jul; 38(7):1234-43. PubMed ID: 21459944
[TBL] [Abstract][Full Text] [Related]
12. Miliary tuberculosis following negative latent tuberculosis infection screening prior to tumor necrosis factor-α antagonists: implications for management?
Teh BW; Street AC; McBryde ES; Denholm JT
J Rheumatol; 2012 Jun; 39(6):1297-8. PubMed ID: 22661422
[No Abstract] [Full Text] [Related]
13. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
[TBL] [Abstract][Full Text] [Related]
14. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
[TBL] [Abstract][Full Text] [Related]
15. Double screening for latent tuberculosis infection in patients treated with anti-tumor necrosis factor α.
Sempau L; González-Sixto B; Sánchez-Sambucetty P; de Morales JM; Pérez-Bustillo A; Rodríguez-Prieto MA
Arch Dermatol; 2011 Oct; 147(10):1233-4. PubMed ID: 22006153
[No Abstract] [Full Text] [Related]
16. Biological agents and tuberculosis: risk estimates and screening strategies.
Dobler CC
Int J Rheum Dis; 2015 Mar; 18(3):264-7. PubMed ID: 25923605
[No Abstract] [Full Text] [Related]
17. Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.
Nobre CA; Callado MR; Lima JR; Gomes KW; Martiniano GV; Vieira WP
Rheumatol Int; 2012 Sep; 32(9):2769-75. PubMed ID: 21822912
[TBL] [Abstract][Full Text] [Related]
18. Active tuberculosis risk with tumor necrosis factor inhibitors after treating latent tuberculosis.
Kwon M; Sung M; Kwon YJ; Song YG; Lee SW; Park MC; Park YB; Lee SK; Song JJ
J Clin Rheumatol; 2014 Mar; 20(2):68-73. PubMed ID: 24561408
[TBL] [Abstract][Full Text] [Related]
19. Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis.
Yamamoto S; Nagatani K; Sato T; Iwamoto M; Takatori S; Minota S
Int J Rheum Dis; 2017 May; 20(5):584-588. PubMed ID: 28524434
[TBL] [Abstract][Full Text] [Related]
20. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
Shobha V; Chandrashekara S; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
Int J Rheum Dis; 2019 Feb; 22(2):280-287. PubMed ID: 30168281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]